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Abstract
Introduction. Myocardial infarction is a directly life-threatening condition, which is the most frequent consequence of 
diseases and deaths in highly developed countries. In Poland there are almost hundred thousand of myocardial infarction 
cases each year and the morbidity increases. The issue of a huge number of myocardial infarctions is meaningful in many 
countries all over the world. About 30% of all the myocardial infarctions are the ones with ST-segment elevation (ACS STEMI).
The purpose of this paper is to analyse how the pre-hospital care has used a standard pharmacological treatment (the 
so-called MONA scheme) in the area of Szczecin. This medical care was performed by Emergency Medical Service in 
case of patients who have ACS STEMI, were hospitalised in Pomeranian Medical University’s (PMU’s) Department of 
Cardiology, survived this period and were discharged from hospital.
Material and methods. Data apply to 603 (68 died, 535 survived) patients, who had acute coronary syndrome (ACS) 
with ST-segment elevation (STEMI) and were referred to the Department of Cardiology in PMU Clinical Hospital No 2 in 
Szczecin. It concerns all the patients who were treated during cardiological accident and emergency in years 2009– 
–2011. Patients who died were excluded from the study.
Results. In the analysed group of patients, morphine was administered to 402 patients (75.5%), oxygen was admini-
stered to 515 patients (96.8%), nitroglycerine was administered to 393 patients (74.0%) and acetylsalicylic acid was 
administered to 493 patients (92.5%), after taking into account the primary transport (taking patients directly to the 
Department of Cardiology) and the secondary transport.
Morphine administration has increased over the years (p = 0.0028). In particular years it varied as follows: in 2009 — 67%; in 
2010 — 79%; in 2011 — 81%. Oxygen supply has increased as follows: in 2009 — 92%; in 2010 — 98.7%; VII–XII 2011 — 100% 
(p = 0.00008). The supply of nitroglycerine has decreased: in 2009 — 38%; in 2010 — 17.2%; in 2011 — 24.4% (p = 0.00001).
Conclusions. 1. Realisation of MONA scheme in case of ACS STEMI is frequent, regardless of the kind of intervening pa-
ramedics team. 2. The supply of medication from MONA scheme, with the exception of nitroglycerine, is not satisfactory 
for patients with ACS STEMI. 3. In case of inferior wall myocardial infarction diagnosis or in case of uncertainty about the 
myocardial infarction’s placement, paramedics team should resign from nitroglycerine administration during pre-hospital 
phase. 4. ECG teletransmission performance in ACS STEMI should be a standard procedure in case of patients with sudden 
pain in the chest, suggesting recent myocardial infarction, and regardless of a presence of a doctor in a paramedics team.
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Introduction
Myocardial infarction is a directly life-threatening condi-
tion, which is the most frequent consequence of diseases 
and deaths in highly developed countries. In Poland 
there are almost one hundred thousand of myocardial 
infarction cases each year and the morbidity increases. 
The issue of a huge number of myocardial infarctions is 
meaningful in many countries all over the world. About 
30% of all the myocardial infarctions are the ones with 
ST-segment elevation (ACS STEMI). It is estimated, that 
the prevalence of myocardial infarction will double in 
years 1990–2030 [1].
The development of Emergency Medical Services and 
its eligibility connected with pharmacotherapy resulted in 
the same pattern of management in case of ACS STEMI 
for every EMS team (‘S’ — specialised and ‘P’ — standard). 
Most of rescue teams in Europe and all over the world 
have technical possibility to make teletransmissions and 
are also able to make medical consultations with a spe-
cialist from an Interventional Cardiology Centre due to the 
team’s appropriate equipment and implementation of ECG 
transmission system. In case of myocardial infarction, the 
dispatcher should give an order to a specialised ‘S’ team 
with a specialist, due to the fact that it is a directly life-
-threatening condition, which can effect in serious cardiac 
disorders, including cardiac arrest. The intervention can be 
performed by a standard ‘P’ team consisting of parame-
dics (which is the only kind of Emergency Medical Service 
in some countries) when patient’s medical history is not 
explicit or if the dispatcher cannot send the specialised ‘S’ 
team to the patient.
The purpose of this paper is to analyse how the pre-ho-
spital care has used a standard pharmacological treatment 
(the so-called MONA scheme) in the area of Szczecin. This 
medical care was performed by Emergency Medical Service 
in case of patients who have Acute Coronary Syndrome 
with ST-segment elevation myocardial infarction, were 
hospitalised in Pomeranian Medical University’s (PMU’s) 
Department of Cardiology, survived this period and were 
discharged from hospital.
Material and methods
Data apply to 603 patients, who had acute coronary syn-
drome (ACS) with ST-segment elevation (STEMI) and were 
referred to the Department of Cardiology in PMU Clinical 
Hospital No 2 in Szczecin. It concerns all the patients who 
were treated during cardiological accident and emergency 
in years 2009, 2010, 2011. Patients who died were exclu-
ded from the study.
I have analysed the documentation concerning the 
paramedics intervention with regard to primary transport 
(first patient transport from the pre-hospital scene directly 
to the Department of Cardiology) and secondary transport 
(inter-hospital transport between two hospitals — to another 
Emergency Department or The Hospital Emergency Ward 
without the possibility of making PCI and then to the De-
partment of Cardiology) in terms of psychical examination 
and standard pharmacological management undertaken 
by medical services in case of ACS STEMI, the so-called 
MONA scheme (morphine, oxygen, nitroglycerine and ace-
tylsalicylic acid [ASA]). Furthermore, the in-hospital records 
were also analysed.
Results
The average age of the patients from the analysed group 
was about 63.4 years (the youngest patient was 31-year-old 
and the oldest patient was 91-year-old, standard deviation 
[SD] 11,4). The group consisted of 173 (32.5%) female 
patients and 362 (67.5%) male patients. The average age 
of women was about 67.4 years and in case of men it was 
61.6 years. On average, women were six years older than 
men (p = 0.00001).
Emergency Medical Service intervened 220 times 
throughout the analysed period by performing the primary 
transport (the direct one) to the Department of Cardiology. 
During the intervention, in 97 cases (44.1%) the standard 
‘P’ ambulances were used (in 2009 — 28 times, in 2010 — 
41, in 2011 — 28 times), while in 123 cases (55.9%) the 
specialised ‘S’ ambulances were used (in 2009 — 33 times, 
in 2010 — 59, in 2011 — 31 times) (Table 1).
Medical documentation analysis has shown that ad-
ministration of medication based on the so-called MONA 
scheme for patients with ACS was done with a similar 
frequency, regardless of the kind of paramedics team.
In the analysed group of patients, morphine was admi-
nistered to 402 patients (75.5%), oxygen was administered 
to 515 patients (96.8%), nitroglycerine was administered 
to 393 patients (74.0%) and ASA was administered to 
Table 1. Primary and secondary transport of patients to the De-
partment of Cardiology with the aim of interventional treatment
The observed variable The amount Percentage [%]
The requested services 
and transport
535 100
EM transport/reported  
in person
315 58.9
EMS 220 41.1 (100.0)
‘P’ ambulance 97 18.1 (44.1)
‘S’ ambulance 123 23.0 (55.9)
EM — Emergency Department; EMS — Emergency Medical Service (‘S’ and ‘P’ teams altogether); 
‘P’ ambulance — the standard one with two paramedics; ‘S’ ambulance — specialised ambulance 
with a doctor
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493 patients (92.5%), after taking into account the primary 
transport (taking patients directly to the Department of 
Cardiology) and the secondary transport.
Morphine administration has increased over the years 
(p = 0.0028). In particular years it varied as follows: in 
2009 — 67%; in 2010 — 79%; in 2011 — 81%. Oxygen supply 
has increased as follows: in 2009 — 92%; in 2010 — 98.7%; 
VII–XII 2011 — 100% (p = 0.00008). The supply of nitrogly-
cerine has decreased: in 2009 — 38%; in 2010 — 17.2%; 
in 2011 — 24.4% (p = 0.00001) (Table 2).
Discussion
Emergency Medical Services are very important in the 
treatment of a patient during pre-hospital stage. During 
this phase, the biggest time delays are noted (including the 
patient’s reaction). It happens repeatedly, that preliminary 
steps taken by paramedics have a big impact not only on the 
patient’s survival, but also on the effects of his treatment, 
which will be undertaken later.
According to the analysed medical documentation, 
603 patients were transferred to the Department of 
Cardiology with ACS STEMI diagnosis. Five hundred and 
thirty-five patients survived myocardial infarction, while 
68 died — respectively 88.7% and 11.3%. The numbers of 
deaths are running from 6 to 14% in in-hospital mortality 
interval observed in the countries which are members of 
ESC and are holding the registers [2]. The average age of 
the patients from the analysed group was around 63.4 ± 
± 11.4 years, which is similar to PL — ACS register, where 
the average age is around 63,5 ± 12.2 years [3].
The observed period was characterised by a slight 
upward trend in the number of occurring ACS STEMI. This 
trend in the territory of Szczecin agglomeration needs to 
be explained in comparison with the trend included in ESC 
guidelines, in which the number of ACS STEMI was lower 
in years 1997–2005 (121–77) in the European scale [4].
Possibly it happens due to the free Emergency Medical 
Services system in Poland — even in cases of the so-called 
unjustified call-outs. Consequently, patients do not have 
to bear additional financial consequences. It is therefore 
possible that it is the result why they notify the Emergency 
Medical Services system faster in cases of distressing 
symptoms. It is worth pointing out, that in some of the 
European Union countries you have to pay for emergency 
ambulance service intervention in each case, regardless 
of having an insurance or not.
While analysing the prevalence of MONA scheme 
implementation in ACS STEMI treatment, it was observed 
that management equally concerned the specialised teams 
(with a doctor) and the standard teams (only paramedics). 
Not all of the patients were taking all medications from 
the scheme. The most used one was oxygen and the least 
used was nitroglycerine. The use of oxygen and morphine 
has increased in the particular years. The administration 
of acetylsalicylic acid (ASA) in case of ACS has reached 
92.5%. The frequency of medication use in other countries 
was similar, e.g. Czech Republic 95.0% [5] and The United 
Kingdom 85.0% [6].
The issue of nitroglycerine use in ACS STEMI
The frequency of medication use was similar, except nitro-
glycerine, in relation to all the analysed group (however, 
the results are not satisfactory). This medication was 
administered almost three times more in the secondary 
transport than in the primary transport. It seems that 
those situations may be caused by the following factors. 
Nitroglycerine has several contradictions, which exclude its 
application and may be relevant to patients with myocardial 
infarction. Ten per cent of the patients from the analysed 
group was diagnosed with hypotonia, which should be ta-
ken into consideration. A separate problem is inferior wall 
myocardial infarction. Due to the fact, that this kind of myo-
cardial infarction is followed by right ventricular myocardial 
infarction (RV), the application of nitroglycerine increases 
left ventricular’s failure. In RV myocardial infarction you 
cannot administer nitroglycerine [7]. It is worth noting, 
that inferior wall myocardial infarction (classical changes 
in ECG leads — II, III and aVF) represents almost a half of 
all of the myocardial infarctions, while inferior wall myocar-
dial infarction is followed by right ventricular myocardial 
infarction. Right-sided ECG should be performed in order 
to diagnose right ventricular myocardial infarction after 
diagnosing inferior wall myocardial infarction. Changes in 
V3R and V4R correspond to the occurring disease. In this 
context, it should be mentioned that those ECG changes 
continue to exist relatively short. In Kumar et al.’s exami-
nation, 59% patients with inferior wall myocardial infarction 
were diagnosed with RV myocardial infarction [8]. In their 
own examinations, 60.1% of cases were connected with 
inferior myocardial infarction (infarct-related artery — 43.7% 
RCA and 16.4% Cx). Serbian examinations have shown the 
following results: 31.0% RCA and 15.5% Cx [9]. In case 
of right ventricular myocardial infarction, nitroglycerine 
Table 2. Types of medication used by paramedics and in Emer-
gency Departments of hospitals, which take part in transferring 
patients with a need of interventional treatment
Medication The amount %/change/p
Morphine 402 75.5 ↑ (0.0028)
Oxygen therapy 515 96.8 ↑ (0.00008)
ASA 493 92.5 ↔
Nitroglycerine 393 74.0 ↓ (0.00001)
ASA — acetylsalicylic acid
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administration may result in deterioration of the heart’s 
haemodynamics and, in consequence, in deterioration of 
patient’s condition. Perhaps less frequent nitroglycerine 
administration in the primary transport was caused by 
a failure to perform teletransmission and/or the correct 
interpretation of ECG recordings and defining the place-
ment of myocardial infarction. It is possible, that Emergency 
Medical Services team did not administer nitroglycerine 
to the point, where myocardial infarction’s placement was 
defined by a doctor in Emergency Department. Such situ-
ation would be an explanation of the increased prevalence 
of medication administration in the secondary transport. 
However, this condition is not a good explanation of this 
huge divergence.
During the analysis of patient’s condition, it is recom-
mended to consider nitroglycerine administration in case 
of ACS STEMI with particular focus on inferior wall myo-
cardial infarction, which may occur. Due to the fact, that 
paramedics team may have problems with the placement 
of myocardial infarction, it is recommended to consider 
performing the ECG teletransmission as a mandatory 
procedure in pre-hospital system, regardless of the kind of 
the intervening team. It is worth noticing that just the act 
of performing teletransmission does not affect the time 
of medical rescue procedure, and the time that it takes 
ranges from two to three minutes. The studies which were 
carried out on ECG teletransmission in various countries 
have shown, that duration of medical interventions during 
pre-hospital stage, as well as during highly specialised 
phase, has decreased [10, 11]. Therefore, in case of 
a myocardial infarction diagnosis or confirmation, it is 
recommended to resign from nitroglycerine administration 
as a standard treatment and also the realisation of the 
MONA scheme. The possibility of excluding right ventricu-
lar myocardial infarction may occur only after performing 
12-lead right-sided ECG, which seems not to be a right 
kind of management and also may cause delay during pre-
-hospital phase. It is worth noting, that Polish paramedics 
do not learn about such diagnostic examination during 
their course of study.
Conclusions
1. Realisation of MONA scheme in case of ACS STEMI is 
frequent, regardless of the kind of intervening paramedics 
team. 2. The supply of medication from MONA scheme, 
with the exception of nitroglycerine, is not satisfactory for 
patients with ACS STEMI. 3. In case of inferior wall myocar-
dial infarction diagnosis or in case of uncertainty about 
the myocardial infarction’s placement, paramedics team 
should resign from nitroglycerine administration during 
pre-hospital phase. 4. ECG teletransmission performance 
in ACS STEMI should be a standard procedure in case of 
patients with a sudden pain in the chest, suggesting recent 
myocardial infarction, and regardless of a presence of 
a doctor in a paramedics team.
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Streszczenie
Wstęp. Zawał serca to stan bezpośredniego zagrożenia życia i najczęstsza przyczyna chorobowości i zgonów w krajach 
wysokorozwiniętych. W Polsce odnotowuje się około 100 tys. zawałów serca rocznie i obserwuje się wzrost chorobowości. 
Ogromna liczba zawałów serca jest poważnym problemem w wielu krajach na całym świecie. Około 30% zawałów serca 
stanowią zawały z uniesieniem odcinka ST (ACS STEMI).
Badanie przeprowadzono w celu przeanalizowania, czy podczas świadczenia opieki przedszpitalnej na terenie Szczecina 
stosowano standardowe leczenie farmakologiczne (tzw. schemat MONA). Oceniano postępowanie zespołów ratownictwa 
medycznego w przypadku chorych z ACS STEMI hospitalizowanych w Klinice Kardiologii Pomorskiego Uniwersytetu Me-
dycznego (PUM) w Szczecinie, którzy przeżyli okres hospitalizacji i zostali wypisani ze szpitala.
Materiał i metody. Dane dotyczyły 603 chorych (68 zmarło, 535 przeżyło), u których wystąpił ostry zespół wieńcowy 
(ACS) w postaci zawału serca z uniesieniem odcinka ST (STEMI) i których przyjęto do Kliniki Kardiologii Szpitala Klinicz-
nego nr 2 PUM. Obejmowały one wszystkich pacjentów, którym udzielono pomocy medycznej w związku ze zdarzeniami 
i nagłymi stanami kardiologicznymi w latach 2009–2011. Chorych, którzy zmarli, wykluczono z badania.
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Wyniki. W analizowanej grupie chorych, przewożonych zarówno bezpośrednio z miejsca zdarzenia do Kliniki Kardiologii, 
jak i między placówkami medycznymi, morfinę podawano 402 osobom (75,5%), tlen — 515 osobom (96,8%), nitroglice-
rynę — 393 osobom (74,0%), kwas acetylosalicylowy — 493 osobom (92,5%).
Stwierdzono zwiększenie częstości podawania morfiny (p = 0,0028). W poszczególnych latach odsetek chorych, u któ-
rych stosowano morfinę, wynosił: w 2009 roku — 67%, w 2010 roku — 79%, w 2011 roku — 81%. Zwiększyło się również 
stosowanie tlenoterapii; w 2009 roku tlen podawano 92% chorych, w 2010 roku — 98,7% chorych, a w okresie VII–XII 
2011 roku — 100% chorych (p = 0,00008). Zmniejszył się natomiast odsetek chorych, którym podano nitroglicerynę; 
w 2009 roku nitroglicerynę stosowano u 38% chorych, w 2010 roku — u 17,2%, w 2011 roku — u 24,4% (p = 0,00001).
Wnioski. 1. W przypadku chorych z ACS STEMI często stosowano schemat MONA, niezależnie od rodzaju zespołu 
ratownictwa medycznego prowadzącego interwencję. 2. Stosowanie leków według schematu MONA u chorych z ACS 
STEMI jest niewystarczające, pomijając nitroglicerynę. 3. W przypadku rozpoznania zawału ściany dolnej serca lub braku 
pewności co do lokalizacji ogniska zawałowego ratownicy powinni zrezygnować z podawania nitrogliceryny na etapie 
opieki przedszpitalnej. 4. Teletransmisja zapisu EKG powinna być standardową procedurą w przypadku podejrzenia ACS 
STEMI u chorych z nagłym bólem w klatce piersiowej sugerującym ostry zawał serca, niezależnie od obecności w lekarza 
w zespole ratownictwa medycznego.
Słowa kluczowe: STEMI, farmakoterapia, schemat MONA, opieka przedszpitalna
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